Sign up for the QMED & MD+DI Daily newsletter.
MD+DI Readers Throw Support Behind Babson's BetterWay Blood TestingMD+DI Readers Throw Support Behind Babson's BetterWay Blood Testing
MD+DI readers voted for Babson Diagnostics as the 2024 Medtech Company of the Year.
Amanda Pedersen
December 4, 2024
2 Min Read
Babson Diagnostics' BetterWay brings an alternative to traditional blood testing with affordable, convenient, and accurate testing in retail pharmacies.Image courtesy of Babson Diagnostics
Earlier this week, MD+DI announced Babson Diagnostics as the editors’ choice for 2024 Medtech Company of the Year. It turns out most readers agreed with us, with nearly 65% of votes going to Babson.
Babson’s BetterWay is blood testing reimagined: convenient and affordable fingertip collection at local pharmacies. Available now in Austin, TX (and expected to be available outside of Austin in the near future), BetterWay is designed to be a customer-first experience, where pharmacy staff collect pea-sized samples from the fingertip instead of vials of blood from the arm. Customers have the choice to self-order or order with a doctor. Babson says that fair prices enable everyone to access routine testing with self-pay, and tests are eligible for insurance and FSA/HSA coverage. Samples are transported from the pharmacy to Babson’s clinical laboratory, and customers receive easy-to-understand results in one to two days.
The following is just a sample of what readers wrote about Babson in the survey comments:
Overcoming the Theranos burden of proof
Great mission, doing things that others couldn't
Groundbreaking technology and legitimate capillary testing could be a game changer for patients
Amazing vision to revolutionize blood testing with amazing data and science!!
Fills such a huge need!
Babson figured out how to do the real version of what Theranos pretended they could do. No one thought it was possible.
They have real potential and the technology is great
Accessibility. I wish this had been in place when I had to continually take my mom to labs for bloodwork.
Making routine blood testing more accessible and convenient will have a profound impact on the entire healthcare system. They achieved commercial readiness and launch this year, and clinicians and providers all rave about the experience so far.
Such an innovative company that is breaking down barriers of blood testing and making health monitoring affordable and accessible.
Potential massive impact in cost and convenience
Babson technology has accomplished what many others have failed to do. Providing healthcare to where the patients are and giving patients options when no one else has for blood testing.
To learn more about Babson Diagnostics and its BetterWay solution, check out: The Year Babson Showed Us a 'BetterWay' to Do Blood Testing
About the Author
You May Also Like
.png?width=300&auto=webp&quality=80&disable=upscale)
.png?width=300&auto=webp&quality=80&disable=upscale)
